Nearly 80% of adults with a previous SARS-CoV-2 infection demonstrated a loss of smell up to 2 years later, according to a ...

Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.

In a recent observational study published in the journal Immunity, researchers from the United States of America investigated the longevity of antibody responses to severe acute respiratory syndrome ...

A recent Lancet Microbe study explores intrahost evolution and the risk factors associated with prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in immunocompromised ...

Health authorities in a central Chinese city on Saturday reported the country's first death from a new type of coronavirus, ...

A new study suggests that a father’s COVID-19 infection could do more than make him sick – it may leave marks on his sperm ...

Authors propose enhancing awareness of risks, close genomic surveillance and early diagnostic tests for symptomatic contacts as part of clinical management of these patients. *Please mention the ...

When a healthy individual suffers from an acute infection, there is an expectation that their immune system will ramp up to fight the invading pathogens and then return to its baseline state. The ...

Detection of common cold coronaviruses (ccCoVs) decreased by approximately half after the widespread SARS-CoV-2 exposure and COVID-19 vaccination, whereas detection of respiratory syncytial virus (RSV ...

FORT LAUDERDALE, FL / ACCESS Newswire / October 9, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a ...